BioMarin to Attend Three Upcoming Investor Conferences
November 03 2016 - 8:30AM
- Credit Suisse 25th Annual Healthcare Conference
on November 7 in Scottsdale, Arizona
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN), today announced that
Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will
participate in the Credit Suisse 25th Annual Healthcare Conference
on November 7, 2016 at 10:00am MT/12:00pm ET, in Scottsdale,
Arizona. Management will also participate in the Jefferies 2016
London Healthcare Conference on November 16, 2016, in London and
the Citi 2016 Global Healthcare Conference on December 8, 2016 at
8:45am ET, in New York City. Webcasts will be available for
the Credit Suisse and Citi conferences. To access the live
webcasts, please visit the investor section of the BioMarin
website, www.BMRN.com. A replay will also be archived on the site
for at least one week following the event.
About BioMarin
BioMarin is a global biotechnology company that
develops and commercializes innovative therapies for people with
serious and life-threatening rare disorders. The company's
portfolio consists of five commercialized products and multiple
clinical and pre-clinical product candidates.
For additional information, please visit
www.BMRN.com. Information on BioMarin's website is not incorporated
by reference into this press release.
Contacts:
Investors
Traci McCarty
BioMarin Pharmaceutical Inc.
(415) 455-7558
Media
Debra Charlesworth
BioMarin Pharmaceutical Inc.
(415) 455-7451
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Mar 2024 to Apr 2024
BioMarin Pharmaceutical (NASDAQ:BMRN)
Historical Stock Chart
From Apr 2023 to Apr 2024